Boise’s Micron reports jaw-dropping sales and profits as its stock price booms

Q2 revenue $23.86B (vs $8.05B a year ago) and profits up ~870% drove a substantial beat; board raised the quarterly dividend 30% to $0.15. Management guided Q3 revenue of $33.5B with gross margin ~81% and is investing ~ $200B in domestic expansion (multiple Boise fabs, NY, VA) plus international fabs in Japan, Singapore and India. Shares have surged ~350% over the past year to an intraday high of $461.73 (closed $422.90), signaling strong market confidence in AI-driven memory demand.

Analysis

Micron’s narrative has shifted the market from cyclicality to structural growth, but the real lever is mix — HBM penetration and higher ASPs can sustain above-average margins without proportional unit growth. That implies equipment, advanced packaging, substrate and nitrogen/chemicals suppliers will capture a disproportionate share of incremental dollar content per wafer, amplifying capex-to-revenue multipliers for suppliers vs pure-memory makers.

Execution risk is asymmetric and multi-horizon: near-term outperformance can persist for quarters on tight HBM supply and stocking by hyperscalers, while longer-term returns hinge on multi-year fab ramps whose benefits arrive well after cash outflows. Key reversal catalysts include a rapid acceleration of competitor capex (quickly oversupplying HBM), hyperscaler vertical integration into memory, or export/regulatory constraints that cut addressable markets.

Investor positioning appears to price not only sustained AI growth but near-perfect fab execution and margin stickiness; that creates distinct tradeable convexity. Use options to capture upside while hedging execution and macro tail risks — the market is ripe for calendar- and capital-structure-sensitive trades rather than outright buy-and-hold equity exposure.

A contrarian read: the magnitude of rerating presumes perpetual share gains against Samsung and SK Hynix — a crowded capex response from them or improved packaging yields elsewhere would compress ASPs quickly. In short, the current move rewards optionality on AI memory demand but punishes exposure to a single-name execution miss or a cyclical reset within 6–24 months.

Key Decisions for Investors

• Long MU via 9–12 month call spread (buy MU 12m $X/$Y call spread) sized 3–5% portfolio: cost-limited upside (max loss = premium) with 2–4x upside if AI-driven pricing and mix persist. Enter on any post-earnings >10% pullback to improve payoff; keep position until next fab execution milestones are confirmed.
• Play capex capture with LRCX (or AMAT) 9–12 month calls sized 2–4% portfolio: equipment exposure benefits earlier in the cycle and has lower single-firm execution risk than fabs. Target 30–50% upside in 9–12 months; trim into strength if order visibility is confirmed by quarterly guides.
• Buy short-dated (1–3 month) protective puts on MU sized to ~25–30% of long exposure as insurance against execution or demand shock: this limits portfolio drawdown from a catastrophic miss while allowing participation in upside via call spread.
• Contrarian hedge: buy a 3–6 month MU out-of-the-money put spread (tight width) sized 1–2% portfolio to monetize a rapid mean reversion should hyperscalers slow stocking or competition accelerates HBM supply. Expect asymmetric payoff if the market re-prices growth expectations within a single quarter.